# Late Scan Time-point Optimalisation of 18F-Fluoroestradiol for the Large Field-of-view (LAFOV) PET/CT Scanner.

> **NCT07627269** · NA · NOT_YET_RECRUITING · sponsor: **University Medical Center Groningen** · enrollment: 8 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **RADIATION:** Late scan time-point(s) optimalisation of 89Zr trastuzumab18F-Fluoroestradiol

## Key facts

- **NCT ID:** NCT07627269
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2030-06-01
- **Final completion:** 2030-08-01
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2026-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07627269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07627269, "Late Scan Time-point Optimalisation of 18F-Fluoroestradiol for the Large Field-of-view (LAFOV) PET/CT Scanner.". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07627269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*